Literature DB >> 12407677

Regression analysis based on pairwise ordering of patients' clinical histories.

Dean A Follmann1.   

Abstract

When a medical treatment influences a variety of outcomes, describing the global effect of treatment can be difficult. Traditional approaches specify how treatment affects each separate outcome. This can be done with separate models for each outcome, or by using a combined multivariate model. Describing the overall effect of a treatment thus requires combining these separate effects in some fashion and can be difficult to explain. In this paper, I specify a regression model for use with multiple outcomes where the outcome histories for each pair of patients are ranked. Pairs of patients with different lengths of follow-up are evaluated solely over the common follow-up interval. The logit of the probability that the outcome for patient i is better than that of patient j is assumed to depend on a linear function of the difference of the covariate vectors (for example, treatment indicators) for persons i and j. Thus covariates directly affect the entire clinical history, rather than directly affecting specific outcomes that comprise the history. The idea is that ranking outcomes is more relevant and interpretable than statistically combining separate effects. An estimating equations approach for estimation is described and an example of a clinical trial involving patients with heart failure is provided. Published in 2002 by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407677     DOI: 10.1002/sim.1272

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  A hierarchical rank test for crossover trials with censored data.

Authors:  Erica Brittain; Dean Follmann
Journal:  Stat Med       Date:  2011-12-05       Impact factor: 2.373

2.  Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME).

Authors:  Scott R Evans; Gene Pennello; Norberto Pantoja-Galicia; Hongyu Jiang; Andrea M Hujer; Kristine M Hujer; Claudia Manca; Carol Hill; Michael R Jacobs; Liang Chen; Robin Patel; Barry N Kreiswirth; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2016-05-18       Impact factor: 9.079

3.  Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step toward Pragmatism in Benefit:risk Evaluation.

Authors:  Scott R Evans; Dean Follmann
Journal:  Stat Biopharm Res       Date:  2016-12-06       Impact factor: 1.452

4.  Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.

Authors:  Sachiko Miyahara; Ritesh Ramchandani; Soyeon Kim; Scott R Evans; Amita Gupta; Susan Swindells; Richard E Chaisson; Grace Montepiedra
Journal:  Clin Infect Dis       Date:  2020-02-03       Impact factor: 9.079

5.  Totality of outcomes: A different paradigm in assessing interventions for treatment of tuberculosis.

Authors:  Grace Montepiedra; Courtney M Yuen; Michael L Rich; Scott R Evans
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.